Company News: Page (1) of 1 - 12/04/17

EMD Serono Receives Health Canada Notice of Compliance for MAVENCLAD™ (cladribine tablets) for patients living with relapsing-remitting multiple sclerosis (RRMS)


December 04, 2017 --
This article is no longer available,but here are some related topics.

Page: 1
Related Keywords:Family,Adults,Family,Computers/Home Office,Communications,Digital Toys,Tablets,Smart Phone,tablet,Tablet,Sales,Marketing,Sales & Marketing,Sales,Sales,Canada,England,USA,Medicine,Disease,healthcare,Surgery,Medication,Science,Medical,

Source:PR Newswire. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved